PATENT CLAIM ANALYSIS

Application Number: 15990734
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "007400"]

Abstract:
There is provided protein biomarkers and methods for their use in diagnosing and treating Inflammatory Bowel Disease (IBD), ulcerative colitis (UC) and Crohn's disease (CD) as well as methods for assessing the severity of the diseases.

Claim (Index 21):
A method for treating ulcerative colitis in a patient comprising:\n wherein ulcerative colitis is detected following an analysis of a sample according to the method of  claim 5 , administering to the patient a compound selected from the group consisting of aminosalycylates, immunomodulators, anti-integrins, anti-cytokines, enteral feed programs, steroids, corticosteroids, antibiotics, anti-TNF\u03b1, and bismuth, or a combination thereof, if the sample is associated with ulcerative colitis.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.28571
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15477508', '14648207', '14743909', '14900867', '14675081']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5419680798871479
- 35 USC 102 Novelty (BERT): 0.6180391361313454
- Combined Prediction Score: 0.5495751855115677
- Mean Citation Score: 351.23441
- Max Citation Score: 634.816
- Similarity Product: 478.0507425308229

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test